MENU
APR 07, 2021 9:00 AM PDT

Keynote Presentation: Doing more with less - Maximizing Phase Appropriate DOE Strategies

Presented at: Bioprocessing 2021
Sponsored by: Roche Diagnostics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Director, Culture Development Seattle Cell Culture Development, Lundbeck Seattle BioPharmaceuticals, Inc
    BIOGRAPHY

Abstract

One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to early stage products can streamline the late stage and commercial development activities. A cell line change between Phase I/II and Phase III can result in spending significant quality, and regulatory resources to demonstrate comparability between the 1st and 2nd generation products. Early DOE screening studies can select for cell lines that have the most robust manufacturability profile, perhaps negating the need for a cell line switch. As the project progresses, process characterization studies can be very labor intensive and are usually delayed until a product has proven itself worthy of investment through success in early clinical trials. Definitive Screening Designs1  have potential to be a one-stop shop for screening important parameters and optimizing settings with low resource costs. Advanced machine learning methods have revolutionized the analysis of large data sets where the data can be divided into portions for training, testing and validation. During bioprocessing development, the datasets are usually small and until now have not been suitable for portioning the data into different training and validation sets. The fractionally weighted bootstrapping method2 uses the same data set for training and validation.  This auto-validation technique has been employed to successfully de-risk model testing experiments that complete the DOE lifecycle.

1  Jones, Bradley and Nachtsheim, Christopher 2011 Definitive Screening Designs with Added Two-Level Categorical Factors  ASQ.org Vol. 45, No. 2, April 2013

2   Ramsey, Phil and Gotwalt, Chris 2017  Model Validation Strategies for Designed Experiments [Power point Slides] Fall Technical Conference https://falltechnicalconference.org/wp-content/uploads/2018_Presentations/3B-FTC-Ramsey-Final.pdf

Learning Objectives:

1. Identify phase appropriate DOE strategies to minimize development timelines and maximize product life-cycle efficiency

2. Recognize the importance of system variability on the DOE settings and levels explored

3. Understand how to use auto-validation to identify model terms


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
Loading Comments...
Show Resources